Inventors:
Tawfik Gharbaoui - Escondido CA, US
Dipanjan Sengupta - San Diego CA, US
Edward Lally - San Diego CA, US
Naomi Kato - San Diego CA, US
Marlon Carlos - Santee CA, US
Natalie Rodriguez - San Diego CA, US
International Classification:
A61K 31/519, C07D 487/02
Abstract:
The present invention relates to processes for preparing pyrazolo[3,4-d]pyrimidine ether compounds that are modulators of glucose metabolism and therefore useful in the treatment of metabolic disorders such as diabetes and obesity.